Leptin serum levels in cachectic and non-cachectic lung cancer patients

Pneumonologia i Alergologia Polska

Volumn 77, Issue 6, 2009, Pages 500-505

  Weryńska, Bozena ^a   Kosacka, Monika ^a   Gołecki, Marcin ^a   Jankowska, Renata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cancer cachexia; Leptin; Lung cancer

Indexed keywords

BIOLOGICAL MARKER; LEPTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CACHEXIA; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NUTRITIONAL STATUS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CACHEXIA; FEMALE; HUMANS; LEPTIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; YOUNG ADULT;

EID: 77949318609     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nelson K.A. The cancer anorexia-cachexia syndrome. Semin. Oncol. 2000; 27: 64-68.
2. Kosacka M., Weryńska B., Gołecki M., Jankowska R., Passowicz-Muszyńska E. Wyste{ogonek}powanie oraz patogeneza zespołu jadłowstre{ogonek}tu i wyniszczenia nowotworowego w raku płuca. Pneumonol. Alergol. Pol. 2008; 76: 360-365.
3. Hang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the obese gene and its human homologue. Nature 1994; 372: 425-432.
4. Meyers J.A., McTiernan A., Ulrich C.M. Leptin and immune function: integrating the evidence. Nutr. Res. 2005; 25: 791-803.
5. Considine R.V., Sinha M.K., Heiman M.L. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996; 334: 292-295.
6. Caro J.F., Kolaczynski J.W., Nyce M.R. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
7. Prolo P., Wong M.L., Licinio J. Leptin. Int. J. Biochem. Cell Biol. 1998; 30: 1285-1290.
8. Sato T., Meguid M.M., Miyata G., Chen C., Hatakeyama K. Does leptin really influence cancer anorexia? Nutrition 2002; 18: 82-83.
9. Krzakowski M. Onkologia kliniczna. Borgis Wydawnictwo Medyczne, Warszawa 2006.
10. Kosacka M., Jankowska R. Epidemiologia raka płuca. Pneumonol. Alergol. Pol. 2007; 75: 76-80.
11. Ruhl C.E., Everhart J.E. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am. J. Clin. Nutr. 2001; 74: 295-301.
12. Simons J.P., Schols A.M., Campfield L.A. et al. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin. Sci. 1997; 93: 273-277.
13. Aleman M.R., Santolaria F., Batista N. et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 2002; 19: 21-26.
14. Tas F., Duranyildiz D., Argon A. et al. Serum levels of leptin and proinflammatory cytokines in advanced-stage non small cell lung cancer. Med. Oncol. 2005; 22: 353-358.
15. Jamieson N.B., Brown D.J., Wallace A.M., McMillan D.C. Adiponectin and systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine 2004; 27: 90-92.
16. Ba{ogonek}czyk M., Gorzelińska L., Łuczak J., Sowiński J. Zespół wyniszczenia nowotworowego. Wpływ leczenia na wybrane parametry kliniczne i biochemiczne. Doniesienie wste{ogonek}pne. Pol. Med. Paliat. 2005; 4: 11-16.
17. Elinav E., Niv-Spector L., Katz M. et al. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology 2009; 150: 3083-3091.